Log in

ABTI Alterola Biotech, Inc. OTC · United Kingdom

Alterola Biotech (ABTI) news

Alterola Biotech, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker ABTI, recorded under United Kingdom. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Alterola Biotech news

We have not published a story on Alterola Biotech yet. When there is news, it will appear here.

Questions about Alterola Biotech

What is the ticker symbol of Alterola Biotech?

Alterola Biotech, Inc. trades under the ticker ABTI on OTC.

Where is Alterola Biotech listed?

Alterola Biotech, Inc. is listed on OTC.

Which country or territory is Alterola Biotech listed under?

Our directory records Alterola Biotech, Inc. under United Kingdom.

What does Alterola Biotech do?

Our directory classifies Alterola Biotech, Inc. as: Biopharma / pharmaceutical profile checked. This is a directory classification, not a description of the pipeline.

What is the ISIN of Alterola Biotech?

The ISIN recorded for Alterola Biotech, Inc. is US02152V1035.

Does aibio.space cover Alterola Biotech?

aibio.space lists Alterola Biotech, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Alterola Biotech?

Companies in our directory listed in the same country and business area as Alterola Biotech: ImmuPharma, Futura Medical, Allergy Therapeutics, OKYO Pharma, Genflow Biosciences Plc, Oxford BioDynamics Plc.

Investor discussion: Alterola Biotech

Members talk about Alterola Biotech (ABTI). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OTC:ABTI on TradingView.

Listing details

Alterola Biotech, Inc. is a public biotech or pharmaceutical company listed on OTC under the ticker ABTI, recorded under United Kingdom. The directory classifies it as Biopharma / pharmaceutical profile checked. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Alterola Biotech, Inc.
Ticker
ABTI
Listing
OTC
Country or territory
United Kingdom
Business scope
Biopharma / pharmaceutical profile checked
ISIN
US02152V1035
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.